ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,050.61
      -0.39%
      US Tech 100
      21,403.60
      -0.57%
      Dow Jones
      43,449.90
      -0.61%
      Brent Oil
      73.175
      0.10%
      Bitcoin
      105,384.23
      -0.72%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aptose Biosciences Inc (APTO)

      7. Aptose Biosciences Inc (APTO) Financials

      Aptose Biosciences Inc

      Aptose Biosciences Inc (APTO)

      NASDAQ
      0.1876
      -0.0016
      (-0.85%)
      Closed December 17 4:00PM
      Delayed by 15 minutes
      0.1919
      0.0043
      (2.29%)
      After Hours: 7:53PM
      Delayed by 15 minutes

      Aptose Biosciences Inc Financial Summary

      The current APTO market cap is 3.48M. The company's latest EPS is USD -2.8276 and P/E is -0.07.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -14.45M-11.68M-9.76M-7.35M-6.97M
      Net Income -14.13M-11.45M-9.64M-7.25M-6.95M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -26.86M-55.77M-65.45M-42.6M-52.36M
      Net Income -26.28M-55.24M-65.35M-41.82M-51.21M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 26.58M20.88M12.8M10.95M10.93M
      Total Liabilities 12.79M13.1M12.66M13.13M20.06M
      Total Equity 13.79M7.78M137k-2.18M-9.13M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 100.48M126.26M82.53M51.03M12.99M
      Total Liabilities 6.55M7.35M8.29M13.29M15.89M
      Total Equity 93.93M118.92M74.24M37.74M-2.9M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.5M-10.54M-11.76M-5.78M-10.38M
      Investing -1.96M12.95M-1.99M2.01M N/A
      Financing 1.1M4.9M11.85M4.75M10.01M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -21.56M-33.89M-43.3M-32.32M-44.59M
      Investing -17.37M12.63M-35.21M30.07M9.96M
      Financing 103.45M58.81M226k116k6.91M

      Stats and Ratios

      Market Cap 3.48M
      Price to Earnings Ratio -0.07
      Price to Sales Ratio 0
      Price to Cash Ratio 0.37
      Price to Book Ratio -1.19
      Dividend Yield -

      Share Statistics

      Shares Outstanding 18.11M
      Average Volume (1 week) 587.22k
      Average Volume (1 Month) 1.93M
      52 Week Change -91.97%
      52 Week High 2.68
      52 Week Low 0.13
      Spread (Intraday) 0.01 (5.26%)

      Company Info

      Company Name Aptose Biosciences Inc
      Address 5955 airport road
      mississauga, ontario L4V 1R9
      Website https://www.aptose.com
      Industry pharmaceutical preparations (2834)